Kuni Foundation Awards 36 Imagination Grants to Advance Innovation and Inclusion in Oregon and Washington
| | Cancer Research, Community, equity, Grants, Intellectual & Developmental Disabilities, PhilanthropyFunded projects include immunotherapeutic hydrogel for pancreatic cancer treatment, advancing precision radiotherapy for tumors, program expansion for neurodiv…
Kuni Foundation Welcomes Robyn Shuey as Director of Grants and Programs
| | Advocacy, Cancer Research, Community, Grants, Intellectual & Developmental Disabilities, PhilanthropyRobyn Shuey is joining the Kuni Foundation as Director of Grants and Programs, a new role that reflects the…
Kuni Foundation Awards $13.2 Million to Oregon and Washington Nonprofits
| | Advocacy, Cancer Research, Community, equity, Grants, Intellectual & Developmental Disabilities, STEMGrants Support Research Dismantling Disparities in Cancer Detection and Treatment for BIPOC Communities; Innovative Housing Solutions for People Experiencing…
PDX Pharmaceuticals Secures Additional Investment from the Kuni Foundation to Advance New Cancer-Fighting Precision Therapies
| | Cancer ResearchPortland, Oregon -- PDX Pharmaceuticals, a privately held company developing first-in-class nanotechnology-based therapies for treating cancer, received a seco…
Improving Bone Marrow Transplant Outcomes for People of Color
| | Cancer ResearchBone marrow transplants have provided life-saving cancer treatments for more than 30 years. As researchers strive to increase survival…
The Tenacious Erin Ryan
| | Cancer ResearchOur work provides daily opportunities to learn and be inspired. It can also challenge assumptions, and we can all…
Endowed Chair Supports Entrepreneurial Research
| | Cancer ResearchA $2.5 million grant from the Kuni Foundation fully funded an endowed chair for Prostate Cancer Research at Oregon…
Collaboration Key to Closing Gaps in Children’s Cancer Research
| | Cancer ResearchThanks to the power of precision medicine, we’re experiencing a revolution in the treatment of cancer, yet progress for…
Kuni Foundation Makes Direct Investment in Company to Advance New Cancer-Fighting Precision Therapy
| | Cancer ResearchVancouver, Washington -- PDX Pharmaceuticals, a privately held company pioneering a new class of therapeutics based on co-delivery of…
OHSU Receives a $7.5 MM Boost for Cancer Research from The Wayne D. Kuni & Joan E. Kuni Foundation
| | Cancer ResearchGrant funds will help launch the OHSU Knight Cancer Institute’s lung cancer research center and create an endowed chair…
Kuni Foundation sets up $50M cancer research fund
| | Cancer ResearchThe Kuni foundation has joined with a Vancouver partner to create a new $50 million fund to support cancer…
$5 Million Donated to OHSU’s Knight Cancer Challenge
| | Cancer ResearchTwo years ago Phil and his wife Penny challenged that if OHSU could raise $500 million, they would match…
